Stockreport

Champions Oncology Third Quarter 2025 Earnings: EPS: US$0.33 (vs US$0.19 loss in 3Q 2024) [Yahoo! Finance]

Champions Oncology, Inc.  (CSBR) 
NASDAQ:AMEX Investor Relations: championsoncology.com/investors
PDF Net income: US$4.50m (up from US$2.53m loss in 3Q 2024). Profit margin: 26% (up from net loss in 3Q 2024). The move to profitability was primarily driven by higher re [Read more]